These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 4380769)

  • 21. The effect of nonaqueous solvents on the quaternary structure of viruses: a procedure for the simultaneous concentration, purification and disruption of influenza viruses.
    Neurath AR; Rubin BA; Sillaman J; Tint H
    Microbios; 1971 Sep; 4(14):145-50. PubMed ID: 5162006
    [No Abstract]   [Full Text] [Related]  

  • 22. Antigenic structure of influenza A viruses; an immunodiffusion study.
    Styk B; Blaskovic D; Hána L; Jakubka J; Sedíleková M
    Acta Virol; 1970 May; 14(3):194-208. PubMed ID: 4392919
    [No Abstract]   [Full Text] [Related]  

  • 23. Antiviral compounds. II. Screening of synthetic organic compounds against influenza virus.
    Nishimura T; Taguchi F; Saito M; Hasegawa K; Nagaki D
    Kitasato Arch Exp Med; 1972 Jun; 45(2):105-23. PubMed ID: 4665956
    [No Abstract]   [Full Text] [Related]  

  • 24. Glycyrrhizic acid inhibits influenza virus growth in embryonated eggs.
    Pompei R; Paghi L; Ingianni A; Uccheddu P
    Microbiologica; 1983 Jul; 6(3):247-50. PubMed ID: 6633273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiviral effect of octyl gallate against influenza and other RNA viruses.
    Yamasaki H; Uozaki M; Katsuyama Y; Utsunomiya H; Arakawa T; Higuchi M; Higuti T; Koyama AH
    Int J Mol Med; 2007 Apr; 19(4):685-8. PubMed ID: 17334645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The dynamics of multiplication of influenza-virus A-2 in mouse lungs under the influence of 1-aminoadamantan preparations].
    Benda R; Rehn F; Dostálová J
    Zentralbl Bakteriol Orig; 1969 Jul; 210(3):298-303. PubMed ID: 5358861
    [No Abstract]   [Full Text] [Related]  

  • 27. [A screening method for anti-influenzal drugs; influenza virus propagation inhibition test (author's transl)].
    Tao SJ
    Zhonghua Yi Xue Za Zhi; 1981 Jun; 61(6):359-61. PubMed ID: 6796238
    [No Abstract]   [Full Text] [Related]  

  • 28. Mechanism of action of T-705 against influenza virus.
    Furuta Y; Takahashi K; Kuno-Maekawa M; Sangawa H; Uehara S; Kozaki K; Nomura N; Egawa H; Shiraki K
    Antimicrob Agents Chemother; 2005 Mar; 49(3):981-6. PubMed ID: 15728892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Methods of isolating the hemagglutinin of the influenza virus (a review)].
    Negrianu GM
    Tr Inst Im Pastera; 1982; 59():98-105. PubMed ID: 6764989
    [No Abstract]   [Full Text] [Related]  

  • 30. [Purification of the A PR 8 influenza virus: problem of the "host cell" antigen bound to the virions].
    Didier J; Bellet S; Lapchine L; Enjalbert L
    Rev Eur Etud Clin Biol; 1970 May; 15(5):558-66. PubMed ID: 4988089
    [No Abstract]   [Full Text] [Related]  

  • 31. Purification, characterization, and structural studies of influenza A2 virus components.
    Hjertén S; Höglund S; Ruttkay-Nedecký G
    Acta Virol; 1970 Mar; 14(2):89-101. PubMed ID: 4392853
    [No Abstract]   [Full Text] [Related]  

  • 32. [Sensitivity of hemagglutinins of some influenza viruses to non-specific inhibitors from the serum of various species of animals].
    Moisa I
    Stud Cercet Virusol; 1972; 23(4):283-300. PubMed ID: 4669950
    [No Abstract]   [Full Text] [Related]  

  • 33. [A comparative study of the effects of actinomycetes of the genera Actinomyces and Micromonospora on the processes of phage, vaccinia and influenza virus multiplication].
    Singal EM; Fadeeva NP; Goncharskaia TIa; Solov'eva NK
    Antibiotiki; 1974 Apr; 19(4):339-41. PubMed ID: 4463872
    [No Abstract]   [Full Text] [Related]  

  • 34. Inactivation of influenza and Newcastle disease viruses by oxidized spermine.
    Bachrach U; Don S
    Isr J Med Sci; 1970; 6(3):435-7. PubMed ID: 5473870
    [No Abstract]   [Full Text] [Related]  

  • 35. [Function of neuraminidase of influenza virus and anti influenza compounds by its inhibition].
    Yamashita M
    Tanpakushitsu Kakusan Koso; 2009 Aug; 54(10):1284-91. PubMed ID: 19663256
    [No Abstract]   [Full Text] [Related]  

  • 36. A study of the active site of influenza virus sialidase: an approach to the rational design of novel anti-influenza drugs.
    von Itzstein M; Dyason JC; Oliver SW; White HF; Wu WY; Kok GB; Pegg MS
    J Med Chem; 1996 Jan; 39(2):388-91. PubMed ID: 8558506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiviral function of pyrrolidine dithiocarbamate against influenza virus: the inhibition of viral gene replication and transcription.
    Uchide N; Ohyama K
    J Antimicrob Chemother; 2003 Jul; 52(1):8-10. PubMed ID: 12775674
    [No Abstract]   [Full Text] [Related]  

  • 38. Antivirals 1980--an update.
    Becker Y; Hadar J
    Prog Med Virol; 1980; 26():1-44. PubMed ID: 6252572
    [No Abstract]   [Full Text] [Related]  

  • 39. Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design.
    Chand P; Babu YS; Bantia S; Chu N; Cole LB; Kotian PL; Laver WG; Montgomery JA; Pathak VP; Petty SL; Shrout DP; Walsh DA; Walsh GM
    J Med Chem; 1997 Dec; 40(25):4030-52. PubMed ID: 9406595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative study of some ketoaldehyde derivatives in relation to their inactivating action in vitro on A-PR8 influenza virus].
    Lorenzutti G; Sapio U; Esposito E
    Boll Soc Ital Biol Sper; 1964 Oct; 40(20):1221-4. PubMed ID: 5877150
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.